Drug Development Consultation Service

NCI Drug Development Consultation Service

The NCI Drug Development Consultation Service is a focused consultation service provided by NCI Developmental Therapeutics Program and Cancer Imaging Program staff, with extensive experience in preclinical development of small molecule, biological or imaging drugs for cancer. 

Investigators from academia or small biotech companies can request this consultation service. The service typically consists of a 1-hour call that could assist you with:

• Drug discovery strategy
• Design of non-clinical safety studies
• Manufacturing plan
• IND plan
• FDA communication
• Superior application for supplemental drug development services to NCI NExT

Request a consultation HERE.

For inquiries on the Drug Development Consultation Service, please contact Greg Evans (evansgl@nih.gov).